AVY
51
-2
MCK
77
2
NUE
44
-2
ED
61
3
AAP
26
2
PEP
51
-2
EA
60
5
GM
40
-3
GT
37
-4
NTRS
45
-4
FLS
50
-2
ALLE
44
16
CHRW
54
-2
FITB
53
10
CTAS
40
-2
AIZ
71
2
AES
52
3
ESS
54
-3
AZO
63
-2
AON
75
-3
AVY
51
-2
MCK
77
2
NUE
44
-2
ED
61
3
AAP
26
2
PEP
51
-2
EA
60
5
GM
40
-3
GT
37
-4
NTRS
45
-4
FLS
50
-2
ALLE
44
16
CHRW
54
-2
FITB
53
10
CTAS
40
-2
AIZ
71
2
AES
52
3
ESS
54
-3
AZO
63
-2
AON
75
-3
Financhill
Back

Palantir Technologies Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
57

PLTR
Palantir Technologies

Last Price:
$79.53
Seasonality Move:
14.94%
Buy
57

SRPT
Sarepta Therapeutics

Last Price:
$98.39
Seasonality Move:
6.73%
Buy
57
Palantir Technologies (PLTR) is a Buy

Is Palantir Technologies a Buy, Sell or Hold?

  • The current Palantir Technologies [PLTR] share price is $79.62. The Score for PLTR is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • PLTR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $98.37. The Score for SRPT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PLTR Stock Price Chart

What is Palantir Technologies's stock price today?

  • The Palantir Technologies share price today is $79.62
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLTR is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $98.37
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

PLTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.28 Sell
Relative Strength Index (14 RSI): 42.27 Sell
Chaikin Money Flow: -52511921 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (83.77 - 113.57) Sell
Bollinger Bands (100): (53.7 - 93.42) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.61 Sell
Relative Strength Index (14 RSI): 35.44 Sell
Chaikin Money Flow: -95412 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (102.36 - 111.78) Sell
Bollinger Bands (100): (109.17 - 127.13) Sell

PLTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 83.08 Sell
20-day SMA: 96.14 Sell
50-day SMA: 86.96 Sell
200-day SMA: 51.54 Buy
8-day EMA: 83.82 Sell
20-day EMA: 89.2 Sell
50-day EMA: 86.23 Sell
200-day EMA: 59.26 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 102.42 Sell
20-day SMA: 105.35 Sell
50-day SMA: 113.41 Sell
200-day SMA: 126.36 Sell
8-day EMA: 102.05 Sell
20-day EMA: 105.46 Sell
50-day EMA: 111.27 Sell
200-day EMA: 120.57 Sell

Palantir Technologies Earnings Growth & PLTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.02 per share, an increase this year of $0.18 per share, and an increase next year of $0.14 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.95 per share, and an increase next year of $4.96 per share.

Palantir Technologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):